Stock overview
Nurix Therapeutics
Explore the company, reported ownership, price history, and available source evidence.
NURIX THERAPEUTICS (NRIX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $14.10
- · NRIX
- Tracked holders
- 4 funds
- Latest available 13F per fund
NRIX · USD
Price
Close · Nov 18, 2026
- Range low
- $4.25
- Range high
- $32.93
- Observations
- 1255
- Session date
- Nov 18, 2026
Nov 18, 2021–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $110,454,363 | 0.52% |
| General Atlantic position history Q3 2026 · filed Nov 13, 2026 · SEC filing | — | $71,893,106 | 2.9% |
| ARK Investment Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | +3% 26'Q3 | $43,924,834 | 0.25% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $1,223,151 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market